Preoperative Education for Less Outpatient Pain After Surgery (PELOPS)
PELOPS
Impact of a Preoperative Education on the Quality of Postoperative Analgesia Management in Outpatient Surgery
2 other identifiers
interventional
412
1 country
1
Brief Summary
In 2015, more than 50% of surgical procedures were performed in outpatient settings. Successful pain management after outpatient surgery is crucial, and requires a perfect cooperation between caregivers and patients, with clear information on the analgesics use at home. Different strategies to control postoperative pain were adopted by hospitals performing outpatient surgery. However, up to half of patients receive little or no information about the treatment of postoperative pain, and at least one third of them are not able to follow postoperative analgesia instructions. There is a clear unmet need in pain treatment during first 48-72 hours after discharge, with important number of emergency calls and readmissions. The most common causes of rescue calls after outpatient surgery are uncontrolled pain and questions about medications or post-operative care. Structured education interventions using psychological techniques to enhance engagement and behavior were found to be beneficial for better acute pain management in outpatient settings after orthopedic surgery. We hypothesize that an educational intervention based on the rational perception of postoperative pain and discomfort, and the proper use of analgesics would improve the quality of pain management at home and reduce analgesics-related side effects. Principal objective of this study is to evaluate the impact of a preoperative educational intervention on effectiveness of postoperative pain self-management in outpatient settings compared to the current practice. Secondary objectives are to evaluate the prevalence of analgesics use and the incidence of severe pain episodes, as well as side effects. The occurrence of neurological pain, quality of sleep, and patient's comfort will be evaluated at 30th day after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedStudy Start
First participant enrolled
January 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedJanuary 29, 2026
January 1, 2026
6.7 years
November 23, 2018
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time-weighted sum of Pain Relief - Total Pain Relief (TOTPAR) during 5 postoperative days
TOTPAR is a global score based on relief of pain. A numerical scale has at its left end the words "no relief = 0" and at its right end "complete relief = 100%". The pain relief score is calculated using the area under the curve for a defined period of time. TOTPAR is also expressed as a percentage of the maximum TOTPAR that would be achieved by treatment that would provide complete relief during the observation period. In order to measure this area under the curve, at least 3 measurements per day will have to be reported in the patient diary.
Day 5
Secondary Outcomes (7)
Time-weighted sum of Pain Relief - Total Pain Relief (TOTPAR)
At Day 10, Day 20 and Day 30 with the initial point at Day 5
Type, number and doses of prescribed analgesics
At Day 0, Day 1, Day 2, Day 3, Day 4, Day 5, Day 10, Day 20 and Day 30.
Incidence of severe pain (≥ 7 out of 10).
From day 0 to the end of stidy (Day 30)
Incidence of side effects (nausea / vomiting / gastralgia / dizziness / concentration disorder / somnolence / constipation, other).
From day 0 to the end of stidy (Day 30)
Prevalence of neuropathic pain assessed by using the DN4 scale.
At Day 30
- +2 more secondary outcomes
Study Arms (2)
Patients with a therapeutic educational intervention
EXPERIMENTALArm 1 : Interventional group: A therapeutic educational intervention is performed following pre-anesthesia assessment
Patients without therapeutic educational intervention
ACTIVE COMPARATORArm 2 : Control group: standard information on pain is performed following pre anesthesia assessment
Interventions
During the usual pre-anesthesia assessment (performed between D-30 and D0 of the intervention), the anesthesiologist will deliver to the intervention group patient oral and visual information on: * the numerical scale of pain ranging from 0 to 10 with examples of perceptions corresponding to each level of the scale (calibration) * nature of postoperative pain (inflammatory character, dynamic over time) * average pain level incurred by the intervention * the difference between anti-inflammatory and opioid analgesics * principles of systematic treatment and pain anticipation * principles of overdose and side effects prevention This information is standardized and delivered orally, accompanied by a visual support (patient diary), which will be given to the patient upon discharge from the hospital
Standard information on pain For patients in the control group the standardized information is based on the SG/DGM/DSS 1/41-2010 scheme of the AFSSAPS-CFETD repository.
Eligibility Criteria
You may qualify if:
- Adults (age ≥ 18 years);
- Patients scheduled for outpatient orthopedic surgery
- ASA (American Society of Anesthesiology) I to III;
- Patients admitted for an outpatient intervention resulting in moderate to severe pain: eg: arthroscopy of the knee or shoulder, cruciate ligaments, shoulder block, medial patellofemoral ligament plasty (not exhaustive)
You may not qualify if:
- Pregnant or lactating women
- Patients with contraindications to paracetamol and/or second-level analgesic and/or NSAIDs (hepatocellular insufficiency, respiratory insufficiency, substituted or unsubstituted drug addicts, allergy to one of the drugs, history of bleeding or digestive perforation during previous NSAID treatment, history of gastroduodenal ulcer, renal failure with clearance \<50mL / min, severe heart failure)
- Patients with preoperative chronic pain (outside operative site, known or detected by DN4)
- Patients admitted for an outpatient arthroplasty (excluded because they are subjected of a specific preoperative preparation)
- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care, persons admitted to a health or social establishment for other purposes than research
- Patient with a poor understanding of French
- Patient refusing to participate to the study
- Patient not affiliated to a social security regimen
- Patient participating in other interventional research except a routine care research (former regulation) and/or research with no interference with the primary endpoint analysis as determined by the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon - Hopital de la Croix Rousse - Anaesthesia Reanimation unit
Lyon, 69004, France
Related Publications (1)
Dziadzko M, Bouteleux A, Minjard R, Harich J, Joubert F, Pradat P, Pantel S, Aubrun F. Preoperative Education for Less Outpatient Pain after Surgery (PELOPS trial) in orthopedic patients-study protocol for a randomized controlled trial. Trials. 2022 May 21;23(1):422. doi: 10.1186/s13063-022-06387-6.
PMID: 35598000DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2018
First Posted
November 27, 2018
Study Start
January 22, 2019
Primary Completion
September 15, 2025
Study Completion
September 15, 2025
Last Updated
January 29, 2026
Record last verified: 2026-01